|
|
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
100 Clinical Results associated with CD3 x 5T4 x NKG2A
100 Translational Medicine associated with CD3 x 5T4 x NKG2A
0 Patents (Medical) associated with CD3 x 5T4 x NKG2A